Rasmus Holm-Jorgensen
Direttore Finanziario/CFO presso ACRIVON THERAPEUTICS, INC.
Patrimonio netto: 230 875 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Rasmus Holm-Jorgensen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
| Extinct | Biotechnology | 27 | |
| Public Company | Pharmaceuticals: Major | 18 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Rasmus Holm-Jorgensen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Rochester Christian University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
| GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Founder Chief Operating Officer | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| Boston College Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| KODIAK SCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| TALIS BIOMEDICAL CORPORATION | Medical Specialties | Chairman Director/Board Member | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Chief Operating Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| Suffolk University | College/University | Director/Board Member Graduate Degree | |
Genomic Life, Inc.
 Genomic Life, Inc. Medical/Nursing ServicesHealth Services Wamberg Genomic Advisors, Inc. engages in the provision of genomic-based programs and services. It offers a comprehensive cancer support program that provide an individual and their family with the dedicated resources, technology, and genetic testing needed to navigate cancer while improving chances of survival. The company was founded in 2017 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ZAI LAB LIMITED | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Vesselon, Inc.
 Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Medical Specialties | Director/Board Member Director/Board Member | |
| D'Amore-Mckim School of Business | College/University | Masters Business Admin Masters Business Admin | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member Compliance Officer | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO General Counsel | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Human Resources Officer | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Director of Finance/CFO | |
| Wallace E Carroll School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Brown University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Regno Unito | 3 |
| Danimarca | 2 |
| Isole Cayman | 2 |
| Canada | 2 |
Settori
| Health Technology | 35 |
| Consumer Services | 12 |
| Commercial Services | 3 |
| Health Services | 3 |
| Finance | 2 |
Posizioni
| Director/Board Member | 221 |
| Corporate Officer/Principal | 122 |
| Independent Dir/Board Member | 90 |
| Undergraduate Degree | 48 |
| Chief Tech/Sci/R&D Officer | 33 |
Contatti più connessi
| Insiders | |
|---|---|
| Felix Baker | 28 |
| Thomas Tisch | 27 |
| Kim Popovits | 19 |
| Ivana Magovcevic-Liebisch | 18 |
| J. Goater | 17 |
| Derek DiRocco | 17 |
| Thomas Malley | 17 |
| Mark Goldberg | 17 |
| Richard Levy | 16 |
| Carsten Boess | 15 |
| Peter Wirth | 15 |
| Matthew Osborne | 14 |
| Charles Baum | 12 |
| Michael Tomsicek | 12 |
| Alicia Secor | 12 |
- Borsa valori
- Insiders
- Rasmus Holm-Jorgensen
- Connessioni Società
